U.S. Physical Therapy, Inc. (NYSE:USPH) Declares Quarterly Dividend of $0.46

U.S. Physical Therapy, Inc. (NYSE:USPH) announced a quarterly dividend on Tuesday, November 3rd. Shareholders of record on Monday, November 16th will be paid a dividend of $0.46 per share on Friday, December 11th. This represents a $1.84 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date is Monday, November 16th.

U.S. Physical Therapy has increased its dividend payment by an average of 0.4% per year over the last three years and has increased its dividend annually for the last 6 consecutive years. U.S. Physical Therapy has a dividend payout ratio of 62.4% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect U.S. Physical Therapy to earn $3.42 per share next year, which means the company should continue to be able to cover its $1.84 annual dividend with an expected future payout ratio of 53.8%.

U.S. Physical Therapy Price Performance

USPH stock opened at $89.66 on Thursday. The firm has a 50 day moving average price of $83.40 and a 200-day moving average price of $76.92. U.S. Physical Therapy has a 52-week low of $58.19 and a 52-week high of $90.94. The firm has a market capitalization of $1.34 billion, a price-to-earnings ratio of 527.45, a PEG ratio of 2.15 and a beta of 1.16. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.27 and a current ratio of 1.27.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Wednesday, November 4th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.76 by $0.04. The company had revenue of $222.56 million for the quarter, compared to the consensus estimate of $214.48 million. U.S. Physical Therapy had a return on equity of 9.39% and a net margin of 3.97%. The firm’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.66 EPS. Equities research analysts forecast that U.S. Physical Therapy will post 2.89 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Citigroup reaffirmed a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 19th. Weiss Ratings reissued a “hold (c-)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 26th. JPMorgan Chase & Co. raised their price objective on shares of U.S. Physical Therapy from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Friday, September 11th. Finally, Barrington Research lifted their target price on shares of U.S. Physical Therapy from $90.00 to $98.00 and gave the stock an “outperform” rating in a report on Monday, August 10th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have given a Hold rating to the company. According to MarketBeat, U.S. Physical Therapy presently has an average rating of “Moderate Buy” and a consensus target price of $98.25.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) operates outpatient physical therapy clinics throughout the United States. The company provides treatment and rehabilitation services for patients recovering from injuries, surgeries, illnesses and other conditions that affect movement, strength and physical function.

In addition to company-operated clinics, U.S. Physical Therapy develops and manages physical therapy practices in partnership with local physical therapists. Its services generally include orthopedic and sports rehabilitation, post-operative therapy, treatment for musculoskeletal conditions and other forms of outpatient rehabilitation.